β-Cell responses to nitric oxide

Vitamins and Hormones

Volumn 95, Issue , 2014, Pages 299-322

  Broniowska, Katarzyna A ^a   Oleson, Bryndon J ^a   Corbett, John A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cytokines; Inducible nitric oxide synthase; Nitric oxide; Type 1 diabetes

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; NITRIC OXIDE; NOS2 PROTEIN, HUMAN;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NECROSIS; PANCREAS ISLET BETA CELL; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; APOPTOSIS; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENDOPLASMIC RETICULUM STRESS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; NECROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84894093437     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800174-5.00012-0     Document Type: Chapter

References (90)

1. Akerfeldt M.C., Howes J., Chan J.Y., Stevens V.A., Boubenna N., McGuire H.M., et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008, 57(11):3034-3044.
2. Allison J., Thomas H., Beck D., Brady J.L., Lew A.M., Elefanty A., et al. Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. International Immunology 2000, 12(1):9-17.
3. Arnush M., Heitmeier M.R., Scarim A.L., Marino M.H., Manning P.T., Corbett J.A. IL-1 produced and released endogenously within human islets inhibits beta cell function. Journal of Clinical Investigation 1998, 102(3):516-526.
4. Arnush M., Scarim A.L., Heitmeier M.R., Kelly C.B., Corbett J.A. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. Journal of Immunology 1998, 160(6):2684-2691.
5. Barbu A.R., Akusjarvi G., Welsh N. Adenoviral-induced islet cell cytotoxicity is not counteracted by Bcl-2 overexpression. Molecular Medicine 2002, 8(11):733-741.
6. Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J.H., Dinarello C.A., Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986, 232(4757):1545-1547.
7. Bonny C., Oberson A., Steinmann M., Schorderet D.F., Nicod P., Waeber G. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. Journal of Biological Chemistry 2000, 275(22):16466-16472.
8. Cardozo A.K., Ortis F., Storling J., Feng Y.M., Rasschaert J., Tonnesen M., et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005, 54(2):452-461.
9. Cetkovic-Cvrlje M., Eizirik D.L. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 1994, 6(4):399-406.
10. Chambers K.T., Unverferth J.A., Weber S.M., Wek R.C., Urano F., Corbett J.A. The role of nitric oxide and the unfolded protein response in cytokine-induced beta-cell death. Diabetes 2008, 57(1):124-132.
11. Christofferson D.E., Yuan J. Cyclophilin A release as a biomarker of necrotic cell death. Cell Death and Differentiation 2010, 17(12):1942-1943.
12. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes 2005, 54(Suppl. 2):S97-S107.
13. Collier J.J., Burke S.J., Eisenhauer M.E., Lu D., Sapp R.C., Frydman C.J., et al. Pancreatic beta-cell death in response to pro-inflammatory cytokines is distinct from genuine apoptosis. PloS One 2011, 6(7):e22485.
14. Collier J.J., Fueger P.T., Hohmeier H.E., Newgard C.B. Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines. Diabetes 2006, 55(5):1398-1406.
15. Comens P.G., Wolf B.A., Unanue E.R., Lacy P.E., McDaniel M.L. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 1987, 36(8):963-970.
16. Corbett J.A., Lancaster J.R., Sweetland M.A., McDaniel M.L. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. Journal of Biological Chemistry 1991, 266(32):21351-21354.
17. Corbett J.A., McDaniel M.L. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochemical Journal 1994, 299(Pt. 3):719-724.
18. Corbett J.A., McDaniel M.L. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. Journal of Experimental Medicine 1995, 181(2):559-568.
19. Corbett J.A., Sweetland M.A., Wang J.L., Lancaster J.R., McDaniel M.L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(5):1731-1735.
20. Corbett J.A., Wang J.L., Hughes J.H., Wolf B.A., Sweetland M.A., Lancaster J.R., et al. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochemical Journal 1992, 287(Pt. 1):229-235.
21. Corbett J.A., Wang J.L., Sweetland M.A., Lancaster J.R., McDaniel M.L. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. Journal of Clinical Investigation 1992, 90(6):2384-2391.
22. Delaney C.A., Green M.H., Lowe J.E., Green I.C. Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Letters 1993, 333(3):291-295.
23. Eizirik D.L. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinologica 1988, 119(3):321-325.
24. Eizirik D.L., Cardozo A.K., Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocrine Reviews 2008, 29(1):42-61.
25. Eizirik D.L., Flodstrom M., Karlsen A.E., Welsh N. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 1996, 39(8):875-890.
26. Eizirik D.L., Mandrup-Poulsen T. A choice of death-The signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44(12):2115-2133. [erratum appears in Diabetologia. 2002 Jun;45(6):936.].
27. Eizirik D.L., Pavlovic D. Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM?. Diabetes/Metabolism Reviews 1997, 13(4):293-307.
28. Eizirik D.L., Sandler S., Welsh N., Cetkovic-Cvrlje M., Nieman A., Geller D.A., et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Journal of Clinical Investigation 1994, 93(5):1968-1974.
29. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB Journal 1989, 3(9):2007-2018.
30. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988, 336(6197):385-388.
31. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology 1989, 172(4-5):413-416.
32. Giannakou M.E., Partridge L. The interaction between FOXO and SIRT1: Tipping the balance towards survival. Trends in Cell Biology 2004, 14(8):408-412.
33. Grunnet L.G., Aikin R., Tonnesen M.F., Paraskevas S., Blaabjerg L., Storling J., et al. Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes 2009, 58(8):1807-1815.
34. Gurzov E.N., Eizirik D.L. Bcl-2 proteins in diabetes: Mitochondrial pathways of beta-cell death and dysfunction. Trends in Cell Biology 2011, 21(7):424-431.
35. Gurzov E.N., Germano C.M., Cunha D.A., Ortis F., Vanderwinden J.M., Marchetti P., et al. p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. Journal of Biological Chemistry 2010, 285(26):19910-19920.
36. Heitmeier M.R., Scarim A.L., Corbett J.A. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. Journal of Biological Chemistry 1997, 272(21):13697-13704.
37. Heitmeier M.R., Scarim A.L., Corbett J.A. Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans. Journal of Biological Chemistry 1999, 274(41):29266-29273.
38. Hibbs J.B., Vavrin Z., Taintor R.R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. Journal of Immunology 1987, 138(2):550-565.
39. Huang H., Tindall D.J. Dynamic FoxO transcription factors. Journal of Cell Science 2007, 120(Pt. 15):2479-2487.
40. Hughes K.J., Chambers K.T., Meares G.P., Corbett J.A. Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated beta-cells that is associated with irreversible DNA damage. American Journal of Physiology. Endocrinology and Metabolism 2009, 297(5):E1187-E1196.
41. Hughes J.H., Colca J.R., Easom R.A., Turk J., McDaniel M.L. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. Journal of Clinical Investigation 1990, 86(3):856-863.
42. Hughes K.J., Meares G.P., Chambers K.T., Corbett J.A. Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression. Journal of Biological Chemistry 2009, 284(40):27402-27408.
43. Hughes K.J., Meares G.P., Hansen P.A., Corbett J.A. FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide. Journal of Biological Chemistry 2011, 286(10):8338-8348.
44. Ignarro L.J. Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension 1990, 16(5):477-483.
45. Iwahashi H., Hanafusa T., Eguchi Y., Nakajima H., Miyagawa J., Itoh N., et al. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: Inhibition by Bcl-2. Diabetologia 1996, 39(5):530-536.
46. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. Journal of Biological Chemistry 1997, 272(49):31138-31148.
47. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Molecular Cell 2005, 17(4):525-535.
48. Lacy P.E. The intraislet macrophage and type I diabetes. Mount Sinai Journal of Medicine 1994, 61(2):170-174.
49. Lacy P.E., Finke E.H. Activation of intraislet lymphoid cells causes destruction of islet cells. American Journal of Pathology 1991, 138(5):1183-1190.
50. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58(2):344-351.
51. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochemical and Biophysical Research Communications 1997, 240(2):419-424.
52. -/-). Diabetes 2000, 49(7):1116-1122.
53. Liu Y., Rabinovitch A., Suarez-Pinzon W., Muhkerjee B., Brownlee M., Edelstein D., et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Human Gene Therapy 1996, 7(14):1719-1726.
54. Mandrup-Poulsen T. Beta-cell apoptosis: Stimuli and signaling. Diabetes 2001, 50(Suppl. 1):S58-S63.
55. Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C.A., Svenson M., Nielsen J.H. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986, 29(1):63-67.
56. Mandrup-Poulsen T., Bendtzen K., Nielsen J.H., Bendixen G., Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 1985, 40(6):424-429.
57. McKenzie M.D., Jamieson E., Jansen E.S., Scott C.L., Huang D.C., Bouillet P., et al. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 2010, 59(3):644-652.
58. Meares G., Hughes K., Jaimes K., Salvatori A., Rhodes C., Corbett J. AMP-activated protein kinase attenuates nitric oxide induced beta-cell death. Journal of Biological Chemistry 2009, 285:3191-3200.
59. Mehmeti I., Lenzen S., Lortz S. Modulation of Bcl-2-related protein expression in pancreatic beta cells by pro-inflammatory cytokines and its dependence on the antioxidative defense status. Molecular and Cellular Endocrinology 2011, 332(1-2):88-96.
60. Mohr S., Zech B., Lapetina E.G., Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochemical and Biophysical Research Communications 1997, 238(2):387-391.
61. Moncada S., Palmer R.M., Higgs E.A. The biological significance of nitric oxide formation from L-arginine. Biochemical Society Transactions 1989, 17(4):642-644.
62. Oyadomari S., Takeda K., Takiguchi M., Gotoh T., Matsumoto M., Wada I., et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(19):10845-10850.
63. Padgett L.E., Broniowska K.A., Hansen P.A., Corbett J.A., Tse H.M. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Annals of the New York Academy of Sciences 2013, 1281:16-35.
64. Papa F.R. Endoplasmic reticulum stress, pancreatic beta-cell degeneration, and diabetes. Cold Spring Harbor Perspectives in Medicine 2012, 2(9):a007666.
65. Pavlovic D., Andersen N.A., Mandrup-Poulsen T., Eizirik D.L. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. European Cytokine Network 2000, 11(2):267-274.
66. Pollock J.S., Forstermann U., Tracey W.R., Nakane M. Nitric oxide synthase isozymes antibodies. Histochemical Journal 1995, 27(10):738-744.
67. Raucci A., Palumbo R., Bianchi M.E. HMGB1: A signal of necrosis. Autoimmunity 2007, 40(4):285-289.
68. Riedl S.J., Salvesen G.S. The apoptosome: Signalling platform of cell death. Nature Reviews. Molecular Cell Biology 2007, 8(5):405-413.
69. Rosales A.L., Cunningham J.M., Bone A.J., Green I.C., Green M.H. Repair of cytokine-induced DNA damage in cultured rat islets of Langerhans. Free Radical Research 2004, 38(7):665-674.
70. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 2000, 141(6):2003-2010.
71. Saldeen J., Lee J.C., Welsh N. Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis. Biochemical Pharmacology 2001, 61(12):1561-1569.
72. Scarim A.L., Heitmeier M.R., Corbett J.A. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology 1997, 138(12):5301-5307.
73. Scarim A.L., Heitmeier M.R., Corbett J.A. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Endocrinology 1998, 139(12):5050-5057.
74. Scarim A.L., Nishimoto S.Y., Weber S.M., Corbett J.A. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage. Endocrinology 2003, 144(8):3415-3422.
75. Schroder M., Kaufman R.J. The mammalian unfolded protein response. Annual Review of Biochemistry 2005, 74:739-789.
76. Southern C., Schulster D., Green I.C. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Letters 1990, 276(1-2):42-44.
77. Spinas G.A., Mandrup-Poulsen T., Molvig J., Baek L., Bendtzen K., Dinarello C.A., et al. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinologica 1986, 113(4):551-558.
78. Steer S.A., Scarim A.L., Chambers K.T., Corbett J.A. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Medicine 2006, 3(2):e17.
79. Storling J., Binzer J., Andersson A.K., Zullig R.A., Tonnesen M., Lehmann R., et al. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 2005, 48(10):2039-2050.
80. Takamura T., Kato I., Kimura N., Nakazawa T., Yonekura H., Takasawa S., et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. Journal of Biological Chemistry 1998, 273(5):2493-2496.
81. Tamura Y., Chiba Y., Tanioka T., Shimizu N., Shinozaki S., Yamada M., et al. NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic beta-cells. FEBS Letters 2011, 585(19):3058-3064.
82. Thomas H.E., Kay T.W. Intracellular pathways of pancreatic beta-cell apoptosis in type 1 diabetes. Diabetes/Metabolism Research and Reviews 2011, 27(8):790-796.
83. Tran V.V., Chen G., Newgard C.B., Hohmeier H.E. Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy. Diabetes 2003, 52(6):1423-1432.
84. Wang M., Zhao X.R., Wang P., Li L., Dai Y., Huang H., et al. Glucose regulated proteins 78 protects insulinoma cells (NIT-1) from death induced by streptozotocin, cytokines or cytotoxic T lymphocytes. International Journal of Biochemistry and Cell Biology 2007, 39(11):2076-2082.
85. Weber S.M., Chambers K.T., Bensch K.G., Scarim A.L., Corbett J.A. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. American Journal of Physiology. Endocrinology and Metabolism 2004, 287(6):E1171-E1177.
86. Weber S.M., Scarim A.L., Corbett J.A. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. American Journal of Physiology. Endocrinology and Metabolism 2003, 284(5):E883-E891.
87. Welsh N., Eizirik D.L., Bendtzen K., Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991, 129(6):3167-3173.
88. Welsh N., Margulis B., Borg L.A., Wiklund H.J., Saldeen J., Flodstrom M., et al. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus. Molecular Medicine 1995, 1(7):806-820.
89. Willis S.N., Fletcher J.I., Kaufmann T., van Delft M.F., Chen L., Czabotar P.E., et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007, 315(5813):856-859.
90. Youle R.J., Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nature Reviews. Molecular Cell Biology 2008, 9(1):47-59.